Stock Track | AdvanSix Stock Plummets 5.12% as Q2 Earnings Miss Estimates, Sales Decline

Stock Track
01 Aug

AdvanSix Inc. (NYSE: ASIX) saw its stock price plummet by 5.12% in pre-market trading on Friday following the release of its second-quarter earnings report. The chemical manufacturing company's financial results fell short of analyst expectations, sparking concerns among investors.

The company reported quarterly earnings of $1.24 per share, missing the analyst consensus estimate of $1.37 by 9.49%. This represents a 20% decrease from earnings of $1.55 per share in the same period last year. Additionally, AdvanSix's quarterly sales came in at $410.02 million, falling short of the analyst consensus estimate of $431.30 million by 4.93%. The reported sales figure marks a 9.58% decrease compared to $453.48 million in the same quarter of the previous year.

Further adding to investor concerns, AdvanSix reported a decrease in its adjusted EBITDA, which fell to $55.675 million from $78.1 million a year ago. The adjusted EBITDA margin also declined from 17.2% to 13.6%. Despite these challenges, the company noted significant sequential improvement in earnings and cash flow from the first quarter, driven by strong performance from its Plant Nutrients business. However, higher raw material costs, particularly for natural gas and sulfur, continue to impact the company's profitability. As the market digests this disappointing earnings report, investors will be closely watching AdvanSix's performance in the coming quarters for signs of recovery.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10